Why rare-disease treatments can be big business

Jan 11, 2016
Combined, Shire and Baxalta expect 65 percent of total revenue to come from rare disease treatments.

For sufferers of rare diseases, options are rare too

Jun 9, 2014
How a mother fought to be heard.

Need some Econ 101?

Our new Marketplace Crash Course is here to help. Sign-up for free, learn at your own pace.